Correlation Between Cardiol Therapeutics and Willow Biosciences

Can any of the company-specific risk be diversified away by investing in both Cardiol Therapeutics and Willow Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiol Therapeutics and Willow Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cardiol Therapeutics Class and Willow Biosciences, you can compare the effects of market volatilities on Cardiol Therapeutics and Willow Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiol Therapeutics with a short position of Willow Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiol Therapeutics and Willow Biosciences.

Diversification Opportunities for Cardiol Therapeutics and Willow Biosciences

0.72

Correlation Coefficient

Cardiol Therapeutics  Willow Biosciences

Poor diversification

The 3 months correlation between Cardiol and Willow is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cardiol Therapeutics Class and Willow Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Willow Biosciences and Cardiol Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiol Therapeutics Class are associated (or correlated) with Willow Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Willow Biosciences has no effect on the direction of Cardiol Therapeutics i.e., Cardiol Therapeutics and Willow Biosciences go up and down completely randomly.

Pair Corralation between Cardiol Therapeutics and Willow Biosciences

Assuming the 90 days trading horizon Cardiol Therapeutics Class is expected to generate 0.88 times more return on investment than Willow Biosciences. However, Cardiol Therapeutics Class is 1.13 times less risky than Willow Biosciences. It trades about 0.05 of its potential returns per unit of risk. Willow Biosciences is currently generating about 0.03 per unit of risk. If you would invest  133.00  in Cardiol Therapeutics Class on September 12, 2024 and sell it today you would earn a total of  71.00  from holding Cardiol Therapeutics Class or generate 53.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cardiol Therapeutics Class  vs.  Willow Biosciences

Cardiol Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Willow Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Willow Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cardiol Therapeutics and Willow Biosciences

The main advantage of trading using opposite Cardiol Therapeutics and Willow Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiol Therapeutics position performs unexpectedly, Willow Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will offset losses from the drop in Willow Biosciences' long position.

The idea behind Cardiol Therapeutics Class and Willow Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.